Home > News > Nano Killers Aim at Mini Tumors
June 22nd, 2004
Nano Killers Aim at Mini Tumors
A company called Kereos is developing a pair of nanotechnologies to identify tumors that measure just 1 mm in diameter, then kill them with a tiny but precise amount of a chemotherapy drug. The technologies, if approved by the Food and Drug Administration, would not only find cancers in their earliest stages before they can do damage or spread, but also deliver a small amount of a drug targeted directly at tumors, which would cause little or no side effects.
NYU Researchers Break Nano Barrier to Engineer the First Protein Microfiber October 23rd, 2014
Iranian Scientists Apply Nanotechnology to Produce Surgery Suture October 23rd, 2014
RF Heating of Magnetic Nanoparticles Improves the Thawing of Cryopreserved Biomaterials October 23rd, 2014
Sopping up proteins with thermosponges: Researchers develop novel nanoparticle platform that proves effective in delivering protein-based drugs October 22nd, 2014